CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.190
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT - Market closed
CureVac Market Cap
CureVac has a market cap or net worth of $718.25 million as of April 23, 2025. Its market cap has increased by 4.82% in one year.
Market Cap
718.25M
Enterprise Value
255.33M
1-Year Change
4.82%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $718.25M, a decrease of -92.70%. That is a compound annual growth rate of -42.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 718.25M | -6.10% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.41B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |